Inhibitory potentials of ivermectin, nafamostat, and camostat on spike protein and some nonstructural proteins of SARS-CoV-2: Virtual screening approach
et al., Jurnal Teknologi Laboratorium, doi:10.29238/teknolabjournal.v11i1.344
, Inhibitory potentials of ivermectin, nafamostat, and camostat on spike protein and some nonstructural proteins.., Jurnal Teknologi Laboratorium, doi:10.29238/teknolabjournal.v11i1.344
In Silico study of ivermectin, camostat, and nafamostat, showing that ivermectin had the best inhibitory action on the SARS-CoV-2 spike protein and Nsp10, while nafamostat had the best results for the other non-structural proteins. Authors note that the combination of ivermectin and nafamostat may be beneficial for COVID-19.
Umar et al., 30 Jun 2022, peer-reviewed, 6 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.